Valuing Bio-Rad using a discounted cash flow model indicates that the BIO stock is overvalued by 20.10%. I do not consider Bio-Rad Laboratories (NYSE:BIO) to be a good investment opportunity. Between ...
Shares of SpaceX competitor Rocket Lab USA climbed to a record high Monday after the company announced two successful ...
Pictured, Rocket Lab technician during the manufacturing process of its space-grade solar cells at the Company’s Albuquerque, ...
Rocket Lab USA shares rose 16% in premarket trading after disclosing two successful satellite launches in less than 24 hours. Shares were trading around $27. On the year, the stock is up 321%. The ...
Policy changes might affect equipment prices and lab budgets in the US. Here’s what economists and industry analysts are ...
In a report issued on November 13, Exane BNP Paribas also initiated coverage with a Buy rating on the stock with a $345.00 price target. See today’s best-performing stocks on TipRanks >> Rocket Lab ...
Labcorp Holdings Inc. LH, or Labcorp, is positioning itself for sustained growth with a series of strategic acquisitions and partnerships. With a growing emphasis on cell and gene therapy, the company ...
Over the next five years, we forecast operating profit margin to expand approximately 500 basis points, from 12.6% in 2023 to ...
Shares of Rocket Lab USA Inc. are up 23.7% in premarket trades after the space-launch company highlighted strong demand for ...
President-elect Donald Trump has named Pete Hegseth, an Army veteran and Fox News host, as his choice for secretary of defense and John Ratcliffe, a hawkish former House lawmaker, to lead the Central ...
Rocket Lab (NASDAQ: RKLB) stock rocketed 11.2% through noon ET Monday after investment bank Stifel raised its price target on Friday. Reports indicate that Stifel analyst Erik Rasmussen raised his ...
Stifel analyst Erik Rasmussen increased his price target on Rocket Lab stock by more than 50% on Friday. Rasmussen is encouraged by progress on Rocket Lab's new Neutron rocketship. The analyst ...